Fulcrum Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
FULC Key Statistics
Stock Snapshot
With a market cap of 463.54M, Fulcrum Therapeutics(FULC) trades at $6.98. The stock has a price-to-earnings ratio of -5.67.
On 2026-03-25, Fulcrum Therapeutics(FULC) stock traded between a low of $6.78 and a high of $7.16. Shares are currently priced at $6.98, which is +2.9% above the low and -2.5% below the high.
The Fulcrum Therapeutics(FULC)'s current trading volume is 506.24K, compared to an average daily volume of 1.42M.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
FULC News
Fulcrum Therapeutics (FULC) announced an update on their ongoing clinical study. Fulcrum Therapeutics is launching an open-label extension study called “An Ope...
Fulcrum Therapeutics (FULC), MedicAlert Foundation, a nonprofit providing medical IDs and emergency medical information services, and Sickle Cell Disease Associ...
Analyst ratings
80%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.